How to Demonstrate the Clinical Impact of Off-Label Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation

被引：0
|
作者：
Kataoka, Naoya [1 ]
Imamura, Teruhiko [1 ]
机构：
[1] Univ Toyama, Dept Internal Med 2, Toyama, Japan
来源：
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY | 2025年
关键词：
D O I：
10.1111/jce.16591
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Safety of off-label dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
    van den Dries, Carline J.
    Pajouheshnia, Romin
    van den Ham, Hendrika A.
    Souverein, Patrick
    Moons, Karel G. M.
    Hoes, Arno W.
    Geersing, Geert-Jan
    van Doorn, Sander
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (02) : 751 - 761
  • [32] Practical Considerations for the Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation
    Stacy, Zachary
    Richter, Sara
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2017, 23 (01) : 5 - 19
  • [33] Improving the use of direct oral anticoagulants in atrial fibrillation
    Di Minno, Giovanni
    Russolillo, Anna
    Gambacorta, Carminio
    Di Minno, Alessandro
    Prisco, Domenico
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2013, 24 (04) : 288 - 294
  • [34] Pattern and Impact of Off-label Underdosing of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Who are Indicated for Standard Dosing
    Cho, Min Soo
    Yun, Ji Eun
    Park, Ji Jeong
    Kim, Yun Jung
    Lee, Jessie
    Kim, Hyungmin
    Park, Duk-Woo
    Nam, Gi-Byoung
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (09): : 1332 - 1338
  • [35] Response by Zhang et al Regarding Article "Off-Label Under- and Overdosing of Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis"
    Zhang, Xin-Lin
    Wang, Hong-Wei
    Xu, Biao
    Xu, Wei
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2022, 15 (05): : 375 - 375
  • [36] Clinical comprehensive evaluation of direct oral anticoagulants for patients with atrial fibrillation in China
    Zhang, Chi
    Gu, Zhi-Chun
    Ma, Er-Li
    Liu, Bing-Long
    Pan, Mang-Mang
    Wang, Jia
    Wang, Xin
    Wu, Bin
    Lin, Hou-Wen
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 79 (12) : 1631 - 1639
  • [37] Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions
    Di Biase, Luigi
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (02):
  • [38] The use of Gastroprotective Agents in Patients with Atrial Fibrillation Initiating Direct Oral Anticoagulants
    Chobanov, Jan
    Man, Kenneth K. C.
    Wong, Ian Chi Kei
    Lau, Wallis
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 237 - 237
  • [39] USE OF DIRECT ORAL ANTICOAGULANTS IN DIALYSIS PATIENTS WITH ATRIAL FIBRILLATION IN THE UNITED STATES
    Siontis, Konstantinos
    Eckard, Ashley
    Bhave, Nicole
    Noseworthy, Peter
    Shah, Nilay
    Yao, Xiaoxi
    He, Kevin
    Stack, Austin
    Balkrishnan, Rajesh
    Saran, Rajiv
    Nallamothu, Brahmajee
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 512 - 512
  • [40] Use of direct oral anticoagulants for treatment of atrial fibrillation in patients with HIV: a review
    West, Timothy A.
    Perram, Jacinta
    Holloway, Cameron J.
    CURRENT OPINION IN HIV AND AIDS, 2017, 12 (06) : 554 - 560
12345